{"prompt": "['2016N277425_02', 'CONFIDENTIAL', '2018N377698_00', '201749', 'AEs. If a complication prolongs hospitalization or fulfills any other serious criteria,', 'the event is serious. When in doubt as to whether \"hospitalization\" occurred or was', 'necessary, the AE should be considered serious.', 'Hospitalization for elective treatment of a pre-existing condition that did not worsen', 'from baseline is not considered an AE.', 'd. Results in disability/incapacity', 'NOTE:', \"The term disability means a substantial disruption of a person's ability to conduct\", 'normal life functions.', 'This definition is not intended to include experiences of relatively minor medical', 'significance such as uncomplicated headache, nausea, vomiting, diarrhea, influenza,', 'and accidental trauma (e.g. sprained ankle) which may interfere or prevent everyday', 'life functions but do not constitute a substantial disruption', 'e.', 'Is a congenital anomaly/birth defect', 'f.', 'Other situations:', 'Medical or scientific judgment should be exercised in deciding whether reporting is', 'appropriate in other situations, such as important medical events that may not be', 'immediately life-threatening or result in death or hospitalization but may jeopardize', 'the subject or may require medical or surgical intervention to prevent one of the', 'other outcomes listed in the above definition. These should also be considered', 'serious.', 'Examples of such events are invasive or malignant cancers, intensive treatment in an', 'emergency room or at home for allergic bronchospasm, blood dyscrasias or', 'convulsions that do not result in hospitalization, or development of drug dependency', 'or drug abuse', 'g.', 'Is associated with liver injury and impaired liver function defined as:', 'ALT 3xULN and total bilirubin* 2xULN (>35% direct), or', 'ALT > 3xULN and INR ** > 1.5.', '*', 'Serum bilirubin fractionation should be performed if testing is available; if unavailable,', 'measure urinary bilirubin via dipstick. If fractionation is unavailable and ALT > 3xULN', 'and total bilirubin > 2xULN, then the event is still to be reported as an SAE.', '**', 'INR testing not required per protocol and the threshold value does not apply to', 'subjects receiving anticoagulants. If INR measurement is obtained, the value is to be', 'recorded on the SAE form.', '12.4.3.', 'Definition of Cardiovascular Events', 'Cardiovascular Events (CV) Definition:', 'Investigators will be required to fill out the specific CV event page of the CRF for the', 'following AEs and SAEs:', 'Myocardial infarction/unstable angina', 'Congestive heart failure', 'Arrhythmias', '76']['2016N277425_02', 'CONFIDENTIAL', '2018N377698_00', '201749', 'Valvulopathy', 'Pulmonary hypertension', 'Cerebrovascular events/stroke and transient ischemic attack', 'Peripheral arterial thromboembolism', 'Deep venous thrombosis/pulmonary embolism', 'Revascularization', '12.4.4.', 'Recording of AEs and SAEs', 'AEs and SAE Recording:', 'When an AE/SAE occurs, it is the responsibility of the investigator to review all', 'documentation (e.g., hospital progress notes, laboratory, and diagnostics reports)', 'relative to the event.', 'The investigator will then record all relevant information regarding an AE/SAE in', 'the electronic CRF and/or paper form as applicable. It is not acceptable for the', \"investigator to send photocopies of the subject's medical records to GSK in lieu of\", 'completion of the GSK, AE/SAE CRF page.', 'There may be instances when copies of medical records for certain cases are', 'requested by GSK. In this instance, all subject identifiers, with the exception of the', 'subject number, will be blinded on the copies of the medical records prior to', 'submission of to GSK.', 'The investigator will attempt to establish a diagnosis of the event based on signs,', 'symptoms, and/or other clinical information. In such cases, the diagnosis will be', 'documented as the AE/SAE and not the individual signs/symptoms.', 'Subject-completed Value Evidence and Outcomes questionnaires and the collection', 'of AE data are independent components of the study.', 'Responses to each question in the Value Evidence and Outcomes questionnaire will', 'be treated in accordance with standard scoring and statistical procedures detailed by', \"the scale's developer.\", 'The use of a single question from a multidimensional health survey to designate a', 'cause-effect relationship to an AE is inappropriate.', '12.4.5.', 'Evaluating AEs and SAEs', 'Assessment of Intensity', 'The investigator will make an assessment of intensity for each AE and SAE reported', 'during the study and will assign it to one of the following categories:', '77']\n\n###\n\n", "completion": "END"}